Meeder Asset Management Inc Immunity Bio, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $1,485 - $5,258	1,100 Added 5.68%	20,452 $37,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $160,132 - $249,217	-36,812 Reduced 65.54%	19,352 $98,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $61,768 - $108,814	16,923 Added 43.13%	56,164 $279,000
Q2 2022 Aug 08, 2022	BUY	$2.68 - $6.14 $105,165 - $240,939	39,241 New	39,241 $146,000
Q2 2021 Aug 09, 2021	SELL	$13.41 - $22.4 $2,467 - $4,121	-184 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$12.83 - $42.25 $2,360 - $7,774	184 New	184 $4,000

213

71.2M

1.64M

1.45M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.3B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.